VEGFA Activates Erythropoietin Receptor and Enhances VEGFR2-Mediated Pathological Angiogenesis (vol 184, pg 1230, 2014)

被引：0
|
作者：
Yang, Z.
Wang, H.
Jiang, Y.
Hartnett, M. E.
机构：
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2015年 / 185卷 / 04期
关键词：
D O I：
10.1016/j.ajpath.2015.01.004
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：1169 / 1169
页数：1
相关论文
共 16 条
  • [1] VEGFA Activates Erythropoietin Receptor and Enhances VEGFR2-Mediated Pathological Angiogenesis
    Yang, Zhihong
    Wang, Haibo
    Jiang, Yanchao
    Hartnett, M. Elizabeth
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (04): : 1230 - 1239
  • [2] Semaphorin 7A Promotes VEGFA/VEGFR2-Mediated Angiogenesis and Intraplaque Neovascularization in ApoE-/- Mice
    Hu, Shuhong
    Liu, Yifei
    You, Tao
    Zhu, Li
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [3] Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway (vol 31, pg 2097, 2010)
    Dong, Yanmin
    Lu, Binbin
    Zhang, Xiaoli
    Zhang, Jing
    Lai, Li
    Li, Dali
    Wu, Yuanyuan
    Song, Yajuan
    Luo, Jian
    Pang, Xiufeng
    Yi, Zhengfang
    Liu, Mingyao
    CARCINOGENESIS, 2012, 33 (04) : 946 - 946
  • [4] Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis (vol 42, pg 2945, 2014)
    Salvati, E.
    Zizza, P.
    Rizzo, A.
    Iachettini, S.
    Cingolani, C.
    D'Angelo, C.
    Porru, M.
    Randazzo, A.
    Pagano, B.
    Novellino, E.
    Pisanu, M. E.
    Stoppacciaro, A.
    Spinella, F.
    Bagnato, A.
    Gilson, E.
    Leonetti, C.
    Biroccio, A.
    NUCLEIC ACIDS RESEARCH, 2014, 42 (22) : 14083 - 14083
  • [5] AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro (vol 58, pg 6082, 2017)
    Wu, Wenyi
    Duan, Yajian
    Ma, Gaoen
    Zhou, Guohong
    Park-Windhol, Cindy
    D'Amore, Patricia A.
    Lei, Hetian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (14) : 6529 - 6529
  • [6] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth (vol 45, pg 2411, 2014)
    Xuan, Zi-Xue
    Li, Lin-Na
    Zhang, Qi
    Xu, Cheng-Wang
    Yang, De-Xuan
    Yuan, Ye
    An, Ying-Hong
    Wang, Shan-Shan
    Li, Xiao-Wen
    Yuan, Shou-Jun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (06)
  • [7] Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis (vol 169, pg 1886, 2006)
    Luo, Yan
    AMERICAN JOURNAL OF PATHOLOGY, 2007, 171 (03): : 1078 - 1078
  • [8] LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells (vol 55, pg 1196, 2014)
    Guo, Z.
    YONSEI MEDICAL JOURNAL, 2014, 55 (06) : 1748 - 1748
  • [9] The Sphingosine-1-Phosphate Receptor S1PR1 Restricts Sprouting Angiogenesis by Regulating the Interplay between VE-Cadherin and VEGFR2 (vol 23, pg 587, 2012)
    Gaengel, Konstantin
    Niaudet, Colin
    Hagikura, Kazuhiro
    Lavina, Barbara
    Muhl, Lars
    Hofmann, Jennifer J.
    Ebarasi, Lwaki
    Nystroem, Staffan
    Rymo, Simin
    Chen, Long Long
    Pang, Mei-Fong
    Jin, Yi
    Raschperger, Elisabeth
    Roswall, Pernilla
    Schulte, Doerte
    Benedito, Rui
    Larsson, Jimmy
    Hellstroem, Mats
    Fuxe, Jonas
    Uhlen, Per
    Adams, Ralf
    Jakobsson, Lars
    Majumdar, Arindam
    Vestweber, Dietmar
    Uv, Anne
    Betsholtz, Christer
    DEVELOPMENTAL CELL, 2012, 23 (06) : 1264 - 1264
  • [10] RETRACTION: Upregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway (Retraction of Vol 12, Pg 11241, 2019)
    Rao, X.
    Wan, L.
    Jie, Z.
    Zhu, X.
    Yin, J.
    Cao, H.
    ONCOTARGETS AND THERAPY, 2023, 16 : 641 - 641
12